Vontobel Holding
DAWN

Vontobel Holding’s Day One Biopharmaceuticals DAWN Stock Holding History

Vontobel Holding’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,944
Closed -$139K – 1106
2024
Q4 		$139K Hold
10,944
– – ﹤0.01% 1035
2024
Q3 		$152K Hold
10,944
– – ﹤0.01% 1020
2024
Q2 		$151K Buy
+10,944
New +$160K ﹤0.01% 1007
2024
Q1 		– Sell
-15,500
Closed -$226K – 1112
2023
Q4 		$226K Sell
15,500
-8,300
-35% -$101K ﹤0.01% 995
2023
Q3 		$292K Hold
23,800
– – ﹤0.01% 898
2023
Q2 		$284K Buy
+23,800
New +$311K ﹤0.01% 932

Other funds holding DAWN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
ECM
Estuary Capital Management Wayzata, Minnesota $598M AUM 1.72% 1-Year Est. Return

Vontobel Holding's DAWN Position: Q1 2025 in Review

Vontobel Holding sold out of Day One Biopharmaceuticals (DAWN) in Q1 2025, closing a stake of 10,944 shares — an estimated $139K sold.

Vontobel Holding first reported a position in DAWN in Q2 2023 and held it in 6 quarters. The position peaked at $292K in Q3 2023. 184 funds tracked by Wall St. Rank hold DAWN as of Q1 2025.

  • Vontobel Holding reported no remaining Day One Biopharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Vontobel Holding sold 10,944 Day One Biopharmaceuticals shares in Q1 2025, an estimated $139K.
  • Vontobel Holding first reported a position in Day One Biopharmaceuticals in Q2 2023 and held it in 6 quarters.
  • Vontobel Holding's Day One Biopharmaceuticals position peaked at $292K in Q3 2023.
  • 184 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2025.

Based on Vontobel Holding's 13F filing for Q1 2025, filed 28 Apr 2025.